Table 1 Summary of patient and tumor characteristics.

From: Evaluation of primary breast cancers using dedicated breast PET and whole-body PET

Characteristics

Value

Number of patients (N)

10

Tumor characteristics

Number of unique tumors (N)

10

Longest diameter by MRI (cm) [median (interquartile range)]

3.4 (2.3–5.6)

Stage II (N)

6

Stage III (N)

4

Age (years) [median (interquartile range)]

46.5 (39.3–57.8)

Body weight (kg) [median (interquartile range)]

66.6 (63.0–68.2)

Menopause status (N)

Pre-menopause (< 50 years)

6

Post-menopause (> 50 years)

4

Subtypes (N)

ER+/PR+/HER2+

2

ER+/PR+/HER2−

4

ER−/PR−/HER2+

1

ER−/PR−/HER2−

3

Nodal status

Number of positive nodes (N)

15

Patients with positive involvement (%)

80%

Patients without positive involvement (%)

20%

  1. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor-2, MRI magnetic resonance imaging.